Soo Jin Oh

3.0k citations
76 papers · 1.7k indexed · 1 hit paper · h-index 21
Topics
Histone Deacetylase Inhibitors Research (7 papers)interferon and immune responses (5 papers)Pharmacogenetics and Drug Metabolism (5 papers)

In The Last Decade

Soo Jin Oh

73 papers receiving 1.7k citations

Hit Papers

Generation of expandable human pluripotent stem cell-deri...2019202620212023201950100150200250

Peers

Soo Jin Oh
Comparison fields: 5 of 125
  • Molecular Biology 619
  • Surgery 311
  • Biomedical Engineering 208
  • Infectious Diseases 201
  • Hepatology 190
Replace Wenbo Wang with:
Wenbo Wang China
Feng Xue China
Hyun Ju Yoo South Korea
Manna Zhang China
Seema Singh India
Behzad Yeganeh Canada
Qian Chen China
Ricardo Sánchez‐Rodríguez Italy
Toshihiro Okamoto Japan
Soo Jin Oh relative to Wenbo Wang China Wenbo Wang's profile →
Citations per field
00.5×2.6×
Wenbo Wang · 1×
Citations per year

Countries citing papers authored by Soo Jin Oh

Since Specialization
Citations

This map shows the geographic impact of Soo Jin Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soo Jin Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soo Jin Oh more than expected).

Fields of papers citing papers by Soo Jin Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soo Jin Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soo Jin Oh. The network helps show where Soo Jin Oh may publish in the future.

Co-authorship network of co-authors of Soo Jin Oh

This figure shows the co-authorship network connecting the top 25 collaborators of Soo Jin Oh. A scholar is included among the top collaborators of Soo Jin Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soo Jin Oh. Soo Jin Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 12
4 1
5 2
6 8
7 18
8 9
9 15
10 26
11 39
12 4
13 28
14 9
15 14
16 3
17 11
18 12
19 13
20 11

About Soo Jin Oh

Soo Jin Oh is a scholar working on Acoustics and Ultrasonics, Biochemistry and Pharmacology, having authored 76 papers that have together received 1.7k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (7 papers), interferon and immune responses (5 papers) and Pharmacogenetics and Drug Metabolism (5 papers). The work is most often cited by research in Hepatology (190 citations), Orthopedics and Sports Medicine (153 citations) and Infectious Diseases (201 citations). Soo Jin Oh has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Ok Sarah Shin, Jae Kyung Lee, Yong Seuk Lee, Jin Goo Kim, Cho‐Rok Jung, Kyung‐Sook Chung, Ho‐Joon Lee, Myung Jin Son, Sang Kyum Kim and Soo Won Lee. Their work appears in journals such as Journal of the American Chemical Society, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026